GB2024007B - Cancer-treating composition containing inductively heatable particles - Google Patents

Cancer-treating composition containing inductively heatable particles

Info

Publication number
GB2024007B
GB2024007B GB7828040A GB7828040A GB2024007B GB 2024007 B GB2024007 B GB 2024007B GB 7828040 A GB7828040 A GB 7828040A GB 7828040 A GB7828040 A GB 7828040A GB 2024007 B GB2024007 B GB 2024007B
Authority
GB
United Kingdom
Prior art keywords
cancer
composition containing
treating composition
inductively heatable
heatable particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7828040A
Other versions
GB2024007A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gordon R T
Original Assignee
Gordon R T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gordon R T filed Critical Gordon R T
Publication of GB2024007A publication Critical patent/GB2024007A/en
Application granted granted Critical
Publication of GB2024007B publication Critical patent/GB2024007B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A61N1/406—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia using implantable thermoseeds or injected particles for localized hyperthermia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB7828040A 1978-06-30 1978-06-27 Cancer-treating composition containing inductively heatable particles Expired GB2024007B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782828941 DE2828941A1 (en) 1978-06-30 1978-06-30 CANCER TREATMENT AGENTS

Publications (2)

Publication Number Publication Date
GB2024007A GB2024007A (en) 1980-01-09
GB2024007B true GB2024007B (en) 1983-04-27

Family

ID=6043278

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7828040A Expired GB2024007B (en) 1978-06-30 1978-06-27 Cancer-treating composition containing inductively heatable particles

Country Status (3)

Country Link
DE (1) DE2828941A1 (en)
FR (1) FR2429591A1 (en)
GB (1) GB2024007B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323056A (en) * 1980-05-19 1982-04-06 Corning Glass Works Radio frequency induced hyperthermia for tumor therapy
FR2508802A1 (en) * 1981-07-03 1983-01-07 Thomson Csf Magnetic powders for use in hyperthermic treatments - e.g. of tumours, heated by hysteresis in alternating magnetic field
EP0093757A1 (en) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
DE3709851A1 (en) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te NMR DIAGNOSTIC LIQUID COMPOSITIONS
DE4419256A1 (en) * 1994-06-01 1995-12-07 Rau Freiherr Von Nagell Helmut Intravenous admin of iron
CA2326977A1 (en) 1998-04-03 1999-10-14 Dupont Pharmaceuticals Company Inorganic material for radioactive drug delivery
KR20180100586A (en) 2015-12-23 2018-09-11 로드아일랜드하스피틀 Heat accelerator composition and method of use
US11076916B2 (en) 2015-12-23 2021-08-03 Rhode Island Hospital Thermal accelerant compositions and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3294686A (en) * 1966-12-27 Pigment particles coated with organo-alumtnum compounds
US3474777A (en) * 1966-02-10 1969-10-28 Amp Inc Method of administering therapeutic agents
DE1284528B (en) * 1967-03-08 1968-12-05 Foerster Device for the elimination of biological tissue by inductively heated bodies with temperature stabilizing properties
DE1692771A1 (en) * 1968-02-24 1972-01-05 Willy Dr Med Seuss Process for the preparation of internally or externally applicable physiologically active substances and agents manufactured according to them
SE372421B (en) * 1968-04-01 1974-12-23 Minnesota Mining & Mfg
US3720761A (en) * 1968-10-14 1973-03-13 W Hunter Injectable radio-pharmaceutical scanning agent and preparation
GB1270410A (en) * 1969-09-25 1972-04-12 Allor Corp Colloidal composition and method of preparing the same
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
US3743714A (en) * 1970-12-04 1973-07-03 Cis Radiopharmaceuticals Inc Novel carrier preparations for injectable radioactive compositions
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
DE2547086A1 (en) * 1975-07-11 1977-01-27 Leveen Harry H METHOD AND DEVICE FOR TREATMENT OF TUMORS
IE43147B1 (en) * 1975-08-04 1980-12-31 Critical Systems Apparatus for treating tumors
SE431214B (en) * 1977-06-02 1984-01-23 Klaus H Mosbach SET TO MAKE MAGNETIC POLYMER PARTICLES BASED ON A PREFERRED BIOLOGY ACTIVE SUBSTANCE

Also Published As

Publication number Publication date
DE2828941C2 (en) 1989-03-16
DE2828941A1 (en) 1980-01-10
GB2024007A (en) 1980-01-09
FR2429591A1 (en) 1980-01-25
FR2429591B1 (en) 1981-06-26

Similar Documents

Publication Publication Date Title
GB2034604B (en) Absorbent material
GB2041249B (en) Atomizer
GB2031400B (en) Coated refractory material
JPS54153891A (en) Ultraviolettcuring solventtfree liquid composition
ZA794240B (en) Novel dosage form
ZA792316B (en) Liquid bleach-softener composition
GB2041210B (en) Filter material
GB2024007B (en) Cancer-treating composition containing inductively heatable particles
GB2018237B (en) Ceramic composition
GB2028171B (en) Powder applicator
JPS5570367A (en) Atomizer
GB2030146B (en) Polyethers containing pendant organosilicon groups
GB2018740B (en) Ceramic composition
GB2012165B (en) Disposable articles
GB2012590B (en) Syringe
JPS5556072A (en) Refractory material
JPS54113616A (en) Refractory coating material
JPS54156396A (en) Fireefighting material composition
GB2023567B (en) Electrooptic ceramic material
JPS5587718A (en) Medicine composition
JPS5455764A (en) Dressing composition
JPS5580773A (en) Antiidielectriccbreakdown ceramic material
JPS5590476A (en) Refractory bonded material
JPS5529351A (en) Counter for table use
GB2015580B (en) Recarburising ferrous materials

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19970627